Forte Biosciences

$39.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.70 (+4.48%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell FBRX and other stocks, options, and ETFs commission-free!

About FBRX

Forte Biosciences, Inc. Common Stock, also called Forte Biosciences, is a clinical stage dermatology company focuses in the treatment of inflammatory skin diseases. It offers FB-401, a live bio-therapeutic product. The company was founded by Paul A. Wagner in 2017 and is headquartered in Torrance, CA. The listed name for FBRX is Forte Biosciences, Inc. Common Stock.

CEO
Paul A. Wagner
Employees
29
Headquarters
Torrance, California
Founded
—
Market Cap
519.59M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
61.17K
High Today
$39.99
Low Today
$38.01
Open Price
$38.50
Volume
45.07K
52 Week High
$53.99
52 Week Low
$6.45

Collections

FBRX Earnings

-$9.52
-$6.35
-$3.17
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours

You May Also Like

JPHY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure